DaVita (NYSE:DVA) Reaches New 52-Week High at $157.91

DaVita Inc. (NYSE:DVA) hit a new 52-week high during trading on Thursday . The stock traded as high as $157.91 and last traded at $157.91, with a volume of 152191 shares traded. The stock had previously closed at $153.99.

Analyst Ratings Changes

Several equities research analysts have commented on DVA shares. StockNews.com lowered shares of DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. UBS Group boosted their price objective on shares of DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Truist Financial boosted their price objective on shares of DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a research report on Tuesday, August 20th. Bank of America boosted their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. Finally, TD Cowen boosted their price objective on shares of DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $157.00.

DaVita Stock Performance

The stock’s 50 day moving average price is $145.17 and its 200 day moving average price is $139.83. The company has a current ratio of 1.16, a quick ratio of 1.12 and a debt-to-equity ratio of 9.94. The company has a market cap of $14.34 billion, a price-to-earnings ratio of 18.59, a P/E/G ratio of 0.88 and a beta of 0.87.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The company’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.08 EPS. On average, analysts expect that DaVita Inc. will post 9.99 EPS for the current fiscal year.

Insider Buying and Selling

In other DaVita news, CFO Joel Ackerman sold 64,029 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total value of $9,928,336.74. Following the completion of the sale, the chief financial officer now owns 111,481 shares of the company’s stock, valued at $17,286,243.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other DaVita news, CEO Javier Rodriguez sold 32,176 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the completion of the transaction, the chief executive officer now directly owns 905,659 shares of the company’s stock, valued at approximately $141,219,407.87. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Joel Ackerman sold 64,029 shares of the firm’s stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the transaction, the chief financial officer now directly owns 111,481 shares of the company’s stock, valued at $17,286,243.86. The disclosure for this sale can be found here. In the last quarter, insiders sold 113,601 shares of company stock valued at $17,525,449. 2.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in DVA. Principal Securities Inc. acquired a new position in shares of DaVita in the 4th quarter valued at about $37,000. Meridian Wealth Management LLC boosted its holdings in shares of DaVita by 2.9% in the 4th quarter. Meridian Wealth Management LLC now owns 5,921 shares of the company’s stock valued at $620,000 after buying an additional 166 shares during the period. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of DaVita in the 4th quarter valued at about $201,000. ING Groep NV boosted its holdings in shares of DaVita by 12,191.7% in the 4th quarter. ING Groep NV now owns 7,375 shares of the company’s stock valued at $773,000 after buying an additional 7,315 shares during the period. Finally, Norges Bank acquired a new position in shares of DaVita in the 4th quarter valued at about $36,626,000. 90.12% of the stock is owned by institutional investors and hedge funds.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.